Fludarabine and cyclophosphamide provides a nonmyeloablative alternative conditioning regimen with low transplant-related mortality and control of high risk disease

Fludarabine and cyclophosphamide provides a nonmyeloablative alternative conditioning regimen with low transplant-related mortality and control of high risk disease

Non-myeloablative allogeneic transplant (NMAT) has a curative potential for patients who are not myeloablative allogeneic transplant (MAT) candidates. We report a phase II trial of a NMAT regimen with cyclophosphamide and fludarabine in 40 patients; 21 of whom had a prior MAT. Day +100 and 1-year tr...

Full description

Bibliographic Details
Main Authors: Pamela Paplham, Theresa Hahn, Karen Dubel, Patricia Lipka, Philip L. McCarthy
Format: Article
Language:English
Published: Elsevier 2014-01-01
Series:Leukemia Research Reports
Subjects:
Non-myeloablative
Allogeneic transplant
Fludarabine
Cyclophosphamide
Online Access:http://www.sciencedirect.com/science/article/pii/S2213048914000028

Internet

http://www.sciencedirect.com/science/article/pii/S2213048914000028

Similar Items